Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 69

1.

Safety of cataract surgery in patients treated with the new oral anticoagulants (NOACs).

Barequet IS, Zehavi-Dorin T, Bourla N, Tamarin I, Moisseiev J, Salomon O.

Graefes Arch Clin Exp Ophthalmol. 2019 Dec;257(12):2671-2676. doi: 10.1007/s00417-019-04488-8. Epub 2019 Oct 22.

PMID:
31641883
2.

Unilateral Refractive Lens Exchange with a Multifocal Intraocular Lens in Emmetropic Presbyopic Patients.

Levinger E, Levinger S, Mimouni M, Trivizki O, Levinger N, Barequet IS, Rabina G.

Curr Eye Res. 2019 Jul;44(7):726-732. doi: 10.1080/02713683.2019.1591460. Epub 2019 May 21.

PMID:
30841762
3.

Health policy regulations pertaining to advanced surgical devices-their socio-economic effects on ophthalmology practice.

Barequet D, Tur-Sinai A, Barequet I.

Isr J Health Policy Res. 2019 Jan 17;8(1):13. doi: 10.1186/s13584-019-0286-8.

4.

Inadvertent corneal pigmentation following cosmetic blepharopigmentation.

Goldberg H, Berger Y, Ben Bassat I, Barequet I.

Am J Ophthalmol Case Rep. 2018 Sep 5;12:52-54. doi: 10.1016/j.ajoc.2018.09.002. eCollection 2018 Dec.

5.

Prophylactic exposure of human corneal endothelial cells to Rho-associated kinase inhibitor reduced apoptosis rate after phacoemulsification: Ex vivo study.

Achiron A, Feldman A, Karmona L, Avizemer H, Barequet IS, Rosner M, Knyazer B, Bartov E, Burgansky Z, Vishnevskia-Dai V.

J Cataract Refract Surg. 2018 Oct;44(10):1261-1266. doi: 10.1016/j.jcrs.2018.04.044. Epub 2018 Aug 29.

PMID:
30172567
6.

Does PACK-CXL Change the Prognosis of Resistant Infectious Keratitis?

Zloto O, Barequet IS, Weissman A, Ezra Nimni O, Berger Y, Avni-Zauberman N.

J Refract Surg. 2018 Aug 1;34(8):559-563. doi: 10.3928/1081597X-20180705-01.

PMID:
30089187
7.

Predictability of Biometry in Patients Undergoing Cataract Surgery.

Sorkin N, Rosenblatt A, Barequet IS.

Optom Vis Sci. 2016 Dec;93(12):1545-1551.

PMID:
27741085
8.

Unusual Histopathological Views of Fuchs' Endothelial Dystrophy.

Zloto O, Barequet I, Rosner M.

Ophthalmology. 2015 Nov;122(11):2158. doi: 10.1016/j.ophtha.2015.09.012. No abstract available.

PMID:
26498080
9.

Novel model of innate immunity in corneal infection.

Rajaiya J, Zhou X, Barequet I, Gilmore MS, Chodosh J.

In Vitro Cell Dev Biol Anim. 2015 Sep;51(8):827-34. doi: 10.1007/s11626-015-9910-2. Epub 2015 May 15.

10.

[Corneal collagen cross-linking novel technique for prevention of keratoconus progression: results after one-year at the Sheba Medical Center].

Berger Y, Ezra-Nimni O, Skaat A, Fogel M, Grinbaum A, Barequet I.

Harefuah. 2015 Feb;154(2):118-21, 135. Hebrew.

PMID:
25856866
11.

Healing rate of corneal erosions: comparison of the effect of chloramphenicol eye drops and ointment and high-concentration hyaluronic acid in an animal model.

Barequet IS, Harizman N, Ziv H, Rosner M.

Cornea. 2014 Oct;33(10):1080-2. doi: 10.1097/ICO.0000000000000215.

PMID:
25119960
12.

Topical bevacizumab for neovascular glaucoma: a pilot study.

Waisbourd M, Shemesh G, Kurtz S, Rachmiel R, Moisseiev E, Zayit-Soudri S, Loewenstein A, Barequet I.

Pharmacology. 2014;93(3-4):108-12. doi: 10.1159/000358600. Epub 2014 Feb 20.

PMID:
24556733
13.

A Surprising Cause for Corneal Edema after Cataract Surgery: A Missed Posterior Chamber Intraocular Lens Haptic Remnant.

Elyashiv S, Barequet I.

Semin Ophthalmol. 2015;30(5-6):450-3. doi: 10.3109/08820538.2013.874477. Epub 2014 Feb 7.

PMID:
24506516
14.

High-dose topical bevacizumab for corneal neovascularization.

Waisbourd M, Levinger E, Varssano D, Moisseiev E, Zayit-Soudri S, Barak A, Loewenstein A, Barequet I.

Pharmacology. 2013;92(5-6):310-4. doi: 10.1159/000356407. Epub 2013 Dec 4.

PMID:
24335191
15.

Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes.

Moisseiev E, Waisbourd M, Ben-Artsi E, Levinger E, Barak A, Daniels T, Csaky K, Loewenstein A, Barequet IS.

Graefes Arch Clin Exp Ophthalmol. 2014 Feb;252(2):331-7. doi: 10.1007/s00417-013-2495-0. Epub 2013 Oct 31.

16.

Wearing time as a measure of success of scleral lenses for patients with irregular astigmatism.

Ortenberg I, Behrman S, Geraisy W, Barequet IS.

Eye Contact Lens. 2013 Nov;39(6):381-4. doi: 10.1097/ICL.0b013e31829e8faa.

PMID:
24145901
17.

Bonding surgical incisions using a temperature-controlled laser system based on a single infrared fiber.

Gabay I, Barequet I, Varssano D, Rosner M, Katzir A.

J Biomed Opt. 2013 Nov;18(11):111416. doi: 10.1117/1.JBO.18.11.111416.

18.
19.

Riboflavin/UVA photochemical therapy for severe infectious keratitis.

Skaat A, Zadok D, Goldich Y, Varssano D, Berger Y, Ezra-Nimni O, Avni I, Barequet IS.

Eur J Ophthalmol. 2014 Jan-Feb;24(1):21-8. doi: 10.5301/ejo.5000330. Epub 2013 Jul 17.

PMID:
23873492
20.

Long-term follow-up after successful treatment of Pythium insidiosum keratitis in Israel.

Barequet IS, Lavinsky F, Rosner M.

Semin Ophthalmol. 2013 Jul;28(4):247-50. doi: 10.3109/08820538.2013.788676. Epub 2013 Apr 29.

PMID:
23627654

Supplemental Content

Loading ...
Support Center